News archive

New guidance to help cervical screening providers reduce cytology backlogs

Cervical screening prevents cancer by detecting abnormalities of the cervix and referring women for potential treatment.

We rely on 50 laboratories across England to report on cervical cytology (sometimes called smear test) samples.

PHE Screening has been working with NHS England over the past year on plans to reduce backlogs caused by this national shortage of cytology capacity.